Skip to main content
Home

GBL

Main navigation

  • About GBL
      About GBL
    • Our purpose
    • Shareholding
    • Governance
      • Board of Directors
      • Board Committees
      • Corporate governance
    • ESG
      • Sustainability
      • GBL ACT
    • Risk Management
    • Business model
  • Portfolio
      Portfolio
    • Listed assets
      • 55% of GBL’s portfolio
      • adidas
      • Concentrix
      • Imerys
      • Ontex
      • Pernod Ricard
      • SGS
      • Umicore
    • Direct private assets
      • 24% of GBL’s portfolio
      • Affidea
      • Canyon
      • Parques Reunidos
      • Sanoptis
      • Voodoo
    • Indirect private assets
      • 20% of GBL’s portfolio
      • Funds
      • Co-investments
    • Third-party asset management
      • 1% of GBL’s portfolio
  • Investors
      Investors
    • GBL Share
      • Stock price & key share information
      • Dividend
      • Total Shareholder Return
      • Capital and form of shares
      • Voting rights and denominator
      • Transactions on GBL shares
    • Key Financial Information
      • Net asset value
      • Net financial position
      • Credit rating
      • Consolidated net result & Cash earnings
      • Glossary
    • Analysts
    • General Meeting
    • Financial Calendar
    • Strategic Update
    • Prospectus
  • Culture & Careers
  • Media Center
      Media Center
    • Press releases
    • Annual & Half-year reports
    • IR Presentations
    • Analyst Presentations
    • Voting rights and denominator
    • Transactions on GBL shares
    • Subscription Form
72.00 €
Stock price
06/13/202517:35
Key Financial Information

Net asset value

Net asset value in EUR per share
03/31/2025

€ 111.17

Total net asset value
03/31/2025

€ 15,385 M

Discount
03/31/2025

38.11%
Scroll to content

Detailed net asset value as of March 31, 2025

% In capital

Share price (in EUR)

EUR million

Listed assets 7,892
SGS 14.65 92.25 2,561
Pernod Ricard 6.83 91.26 1,573
Imerys 54.72 29.94 1,392
adidas 3.51 216.70 1,369
Concentrix 13.64 51.45 461
Umicore 15.92 9.55 375
Ontex 19.98 8.49 140
TotalEnergies 0.01 59.66 16
GEA 0.06 55.90 6
Direct private assets 3,470
Affidea 99.12 1,592
Sanoptis 84.80 1,017
Voodoo 15.01 303
Parques Reunidos 23.00 296
Canyon 49.84 261
GBL Capital 99.99 2,810
Sienna Investment Managers 100.00 136
Portfolio 14,308
Treasury shares 999
Gross debt (3,070)
Gross cash 3,145
Concentrix note 4
Net asset value (global) 15,385
Net asset value (in EUR per share) 111.17
Share price (in EUR per share) 68.80
Discount (in %) 38.1%

Historic data (total NAV) since 1998

NAV per share and stock price of GBL since 2004

 

Principles

The change in GBL’s net asset value is, together with the change in its stock price, cash earnings and result, an important criterion for assessing the performance of the group.

The net asset value is a conventional reference obtained by adding gross cash, the present value of the Concentrix note (calculated at the market rate, taking into account Concentrix's credit quality) and treasury shares to the fair value of the investment portfolio and deducting gross debt.

The following valuation principles are applied for the portfolio:

  • investments in listed companies and treasury shares are valued at the closing price. However, the value of shares underlying any commitments made by the group is capped at the conversion/exercise price;
  • investments in unlisted companies are valued on a quarterly basis at their fair value in line with the recommendations of the International Private Equity and Venture Capital Valuation Guidelines ("IPEV Valuation Guidelines"). Recent investments are valued at their acquisition cost, provided that these valuations are considered as the best estimates of fair value;
  • regarding GBL Capital’s portfolio, its value corresponds to (i) the sum of its various investments, at fair value, notably on the basis of information provided by the fund managers, to which is added (ii) the external net cash or net debt of GBL Capital;
  • lastly, the assets of Sienna Investment Managers are valued at the fair market value of the acquired management companies.

GBL’s net asset value is reported together with the results’ publication on a quarterly basis.

Some minor events may not have been taken into account in the value reported. The combined effect of these factors may not exceed 2% of the net asset value.

The number of GBL shares used to calculate the net asset value per share is the number of company shares outstanding on the valuation date.

Main navigation

  • About GBL
      About GBL
    • Our purpose
    • Shareholding
    • Governance
      • Board of Directors
      • Board Committees
      • Corporate governance
    • ESG
      • Sustainability
      • GBL ACT
    • Risk Management
    • Business model
  • Portfolio
      Portfolio
    • Listed assets
      • 55% of GBL’s portfolio
      • adidas
      • Concentrix
      • Imerys
      • Ontex
      • Pernod Ricard
      • SGS
      • Umicore
    • Direct private assets
      • 24% of GBL’s portfolio
      • Affidea
      • Canyon
      • Parques Reunidos
      • Sanoptis
      • Voodoo
    • Indirect private assets
      • 20% of GBL’s portfolio
      • Funds
      • Co-investments
    • Third-party asset management
      • 1% of GBL’s portfolio
  • Investors
      Investors
    • GBL Share
      • Stock price & key share information
      • Dividend
      • Total Shareholder Return
      • Capital and form of shares
      • Voting rights and denominator
      • Transactions on GBL shares
    • Key Financial Information
      • Net asset value
      • Net financial position
      • Credit rating
      • Consolidated net result & Cash earnings
      • Glossary
    • Analysts
    • General Meeting
    • Financial Calendar
    • Strategic Update
    • Prospectus
  • Culture & Careers
  • Media Center
      Media Center
    • Press releases
    • Annual & Half-year reports
    • IR Presentations
    • Analyst Presentations
    • Voting rights and denominator
    • Transactions on GBL shares
    • Subscription Form

Groupe Bruxelles Lambert (GBL)

Avenue Marnix 24
B-1000 Brussels

Contact

Reception
+32 2 289 17 86
cdumasy@gbl.com

Investor Relations

Alison Donohoe
+32 2 289 17 64
adonohoe@gbl.com
 

© 2025 GBL, all rights reserved

Footer Menu

  • Legal Notice
  • General Privacy Policy
  • Cookie policy

Made by Globule Bleu